|
WHAT'S THIS?
|
ADVERTORIALS << Datavision: The publication planner’s lifeline (ADVERTORIAL)
|
Datavision: The publication planner’s lifeline (ADVERTORIAL)
Published 2 February 2009, written by Cara Coffey of Envision
Datavision, the premier publications planning software developed and supported by Envision Pharma, is the world’s leading application for publications planning professionals. In just 6 years, the introduction of Datavision and its adoption by the industry has revolutionized the publication planning paradigm such that Datavision is the gold standard to which competing brands are compared. What accounts for such success?
Ease of use
Right out of the box and upon download, Datavision provides fully automated publications planning. Its friendly, intuitive platform allows users to move easily from database population to strategic planning and analysis, to plan and document management and review, and to plan monitoring and continuous improvement.
Users get acclimated to Datavision through our customized implementation and training process, which is divided into adoption phases. In addition, our Customer Care team is available to help all users realize the enormous potential the tool offers.
The right mix of features and functionality
Everything about Datavision is designed with the publication planner in mind. For as complex as managing publications plans sometimes is, the appearance of Datavision is surprisingly simple and elegant. The layout is logical and highly navigable.
In Datavision, the publication planner can store contact details of—and easily contact—all stakeholders involved in the publications planning process. General information about the product can be entered in the Profile area and detailed data about the product’s studies and trials can be stored in the Studies section. Journals and congresses can be researched from a vast database Envision Pharma supports, and selected journal and congress records can be imported into the client’s Datavision plan for ready reference. The Library section allows the team to store the published articles as well as all pertinent resources used in developing the finished papers.
The real muscle of Datavision, however, is in its Documents, Reports, Chart View, and Workbench areas. The Documents area is where users create and manage all documents generated in the plan---such as abstracts, posters, presentations, and manuscripts. In this section, best practice workflow templates are available to foster efficiency and consistency in document development across teams. Document version control and review and approval are easily facilitated, enabling a compliant auditable trail.
Another key to publications planning efficiency is communicating the progress of the plan to stakeholders. Datavision features on-demand, robust reporting capabilities in its Reports section. With one click, teams can generate reports that analyze the status of a single document or that review the status of an entire program or suite of products. The reporting functionality has proven to be an extremely important feature of Datavision particularly because it allows teams to review metric data to evaluate how efficiently the plan is progressing. Gaps and bottlenecks are identified quickly, allowing the team to make any necessary modifications to improve.
Similar to the reporting feature, Datavision’s Chart View is truly the hallmark characteristic of the tool. Datavision’s Chart View links all of the data maintained throughout Datavision and portrays it visually to allow teams to literally see where they have been, where they are, and where they plan to go with their data dissemination goals. Like the Reports section, the Chart View can be modified with customized filters so that teams can see as much or as little of the plan they would like, at any given point of reference, such as dates or milestones.
The Workbench is each user’s homepage when they launch Datavision. Here, each team member can quickly see what tasks they and their team need to accomplish to keep the plan on track. Team meetings are scheduled on the Workbench calendar and general notices to the team can be posted for quick, simultaneous broadcasting.
More and more users opt for an additional feature, the Finance Module, which helps the team create, maintain, and track their publications plan budgets, tracking the actual cost of each document within the plan. With this feature, invoices can be easily reconciled against work completed at any given time-point.
Scalability
Datavision can be used to manage a single product or, more commonly, can be used to manage an entire portfolio of compounds within a company. Through 2007, the most recent year for which data are available, Datavision has seamlessly grown to enable:
10,000+ users worldwide
45,000+ documents (with outcome)
15,000+ reviews (with at least 1 feedback)
60,000+ feedbacks
41,000+ reports (in 2007 only)
In addition, through 2007, our Datavision Team has:
Supported more than 1,800 general requests and hotline calls
Maintained 6,000+ unique journal and congress records
Our community of users has grown so large, in fact, that Envision Pharma regularly hosts a Datavision Industry Forum program.
Compliance assurance
Prior to the availability of Datavision, companies lacked a consistent means to strategize, plan, develop, and execute publications programs to disseminate data resulting from their clinical trial programs to medical congresses and journals. Envision Pharma recognized a strong need to provide such a solution to industry that would offer a consistent, step-by-step approach to publications planning and execution, particularly in light of legislative requirements in the United States, namely, the Food and Drug Administration Amendments Act, Title VIII Clinical Trial Databases, Sec. 801 Expanded Clinical Trial Registry Data Bank (FDAAA), which were increasingly impacting how and when clinical trials should be registered and when data from these trials should be reported.(Ref 1)
Concurrent with the decade-long run-up to and recent enactment of FDAAA was increased governmental and public pressure for industry to exhibit transparency in its interactions with external physician authors and in its publication practices and processes in general. In response to such scrutiny and pressure, publication guidelines were subsequently updated or generated new from such stakeholders as the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the American Medical Writers Association (AMWA) and the European Medical Writers Association (EMWA), and the Good Publication Practice for pharmaceutical companies. In addition, groups such as the International Society for Medical Publication Professionals (ISMPP) and the Committee on Publication Ethics (COPE) were formed. The publications planning environment thus became a very complex landscape.
As the FDAAA legislation continues to roll out, it will be increasingly important for companies to have an auditable trail of their publication development practices and processes. Datavision provides a ready, out-of-the-box means to achieve compliance with these regulations as well as with industry and medical journal/publisher guidelines and internal company publication policies.
For more information:
Datavision is available by license to healthcare organizations. For information about how your company can obtain Datavision, please contact Mike Kramer at Envision Technology Solutions (E: mike.kramer@envisionpharma.com).
If you are already a registered Datavision user and would like more information about how to use the tool or about the growing Datavision community, please e-mail our Customer Care team at datavision@envisionpharma.com
Reference
1. Food and Drug Administration Amendments Act of 2007. The Library of Congress Web site. http://thomas.loc.gov Accessed December 15, 2008.
About the author
Cara Coffey (E: cara.coffey@envisionpharma.com) is a member of the Management and Business Planning teams at Envision Pharma, part of the United BioSource Corporation family of companies. She has been with Envision Pharma, a leading global medical communications company specializing in publications planning services and software, since its inception and has played a key role in the organization’s successful growth.
|
Feedback: Do you have any comments about this article? Contact the Publisher, Peter Llewellyn.
|
|
|
